According to the release, this is the first study globally to demonstrate that Sinapic acid, when administered orally, can accelerate diabetic wound healing in preclinical models. The research established that the compound works by activating the SIRT1 pathway, which plays a crucial role in tissue repair, angiogenesis, and inflammation control.
Related Posts
Karnataka govt ask officials to keep vigil over cough syrups after child deaths in MP, Rajasthan
Post Views: 25 Amid concerns over the quality of cough…
India showcases evidence-based initiatives in traditional medicine at 16th WHO-IRCH meeting
Post Views: 19 The 16th annual meeting of the World…
Sun Pharma launches Leqselvi in the US
Post Views: 39 Sun Pharma has launched Leqselvi (deuruxolitinib, 8 mg)…
